ProCE Banner Activity

My Management Strategies for NASH in Patients With HIV

Clinical Thought
Here’s my take on why abnormal ALT is never “normal” and why patients with HIV and abnormal liver enzymes need our attention.

Released: January 10, 2022

Expiration: January 09, 2023

No longer available for credit.

Share

Faculty

Mark S. Sulkowski

Mark S. Sulkowski, MD

Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grant provided by

Theratechnologies

Faculty Disclosure

Primary Author

Mark S. Sulkowski, MD

Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Mark S. Sulkowski, MD, has disclosed that he has received consulting fees from AbbVie, Assembly Bio, Antios, Gilead Sciences, Virion, and ViiV and has received funds for research support from AbbVie, Assembly Bio, Gilead Sciences, and Janssen.